Tarsus Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.
Tarsus Pharmaceuticals has raised $376M across 4 funding rounds on record, the most recent an undisclosed round of $125M announced in Mar 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tarsus Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Tarsus Pharmaceuticals Funding Rounds
Tarsus Pharmaceuticals raised $75.6M in a Post-IPO Equity announced in May 2022.
1.3 years later, an undisclosed round of $100M was announced in Aug 2023.
8 months later, an undisclosed round of $75.0M was announced in Apr 2024.
11 months later, an undisclosed round of $125M was announced in Mar 2025.
Tarsus Pharmaceuticals Founders and Leadership Team
Contact details for the Tarsus Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Tarsus Pharmaceuticals Funding Compared to Other Biotechnology Startups
Tarsus Pharmaceuticals' latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tarsus Pharmaceuticals in Biotechnology and Irvine
Companies Similar to Tarsus Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Tarsus Pharmaceuticals Funding FAQs
What does Tarsus Pharmaceuticals do?
Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.
How much funding has Tarsus Pharmaceuticals raised?
Tarsus Pharmaceuticals has raised $376M across 4 rounds on record. The most recent is an undisclosed round of $125M announced in Mar 2025.
When did Tarsus Pharmaceuticals last raise funding?
Tarsus Pharmaceuticals' most recent funding round on record is an undisclosed round of $125M, announced in Mar 2025.
Who founded Tarsus Pharmaceuticals?
FundedIQ lists Bobak Azamian (Founder) at Tarsus Pharmaceuticals.
Where is Tarsus Pharmaceuticals headquartered?
Tarsus Pharmaceuticals is based in Irvine, California, United States.
How many employees does Tarsus Pharmaceuticals have?
Tarsus Pharmaceuticals is in the 101-250 employee band.
How does Tarsus Pharmaceuticals' funding compare to other Biotechnology startups?
Tarsus Pharmaceuticals' latest round of $125M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Tarsus Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tarsus Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.